Supplementary Table S3 from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
收藏数据链接：
官方服务：
资源简介：
HER2 counting at a single cell level
创建时间：
2021-10-01
